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Allergy is an immune response to complex mixtures
of multiple allergens, yet current models use a single
synthetic allergen. Multiple allergens were modeled
using two well-defined tetravalent allergens, each
specific for a distinct IgE, thus enabling a systematic
approach to evaluate the effect of each allergen and
percentage of allergen-specific IgE on mast cell
degranulation. We found the overall degranulation
response caused by two allergens is additive for
low allergen concentrations or low percent specific
IgE, does not change for moderate allergen concen-
trations with moderate to high percent specific IgE,
and is reduced for high allergen concentrations
with moderate to high percent specific IgE. These re-
sults provide further evidence that supraoptimal IgE
crosslinking decreases the degranulation response
and establishes the two-allergen model as a relevant
experimental system to elucidate mast cell degranu-
lation mechanisms.
INTRODUCTION
Common allergen sources such as peanuts contain complex
mixtures of allergens. Recent efforts have been made to identify
each allergen present in the mixtures to determine the major al-
lergens that are capable of eliciting a degranulation response in
the majority of patients who possess the specific allergy. For
example, of the 11 different proteins present in peanuts that
are capable of inducing immunoglobulin E (IgE) antibody produc-
tion, 4 have been identified as major allergens (Zhuang and Dre-
skin, 2013). Of the four major peanut allergens, Ara h 2 and Ara h
6 are responsible for the majority of the degranulation response
initiated by crude peanut extract (CPE) (Porterfield et al., 2009).
Interestingly, removal of either Ara h 2 or Ara h 6 from CPE
does not affect the activity of the crude extract (Chen et al.,
2011). However, if both are removed, the potency of the CPE is
significantly diminished, indicating that the presence of the sec-
ond major allergen has negligible effects on the degranulation
response (Chen et al., 2011). Despite the presence of multiple
major allergens capable of inducing a degranulation response
in a natural system, current models use only a single synthetic
allergen paired with a single monoclonal IgE to stimulate aChemistry & Biology 21, 1445–145degranulation response (Passante and Frankish, 2009). Even
with their limitations, the current models have helped to discover
critical aspects of mast cell signaling. Of particular interest,
recent work has identified the Src homology 2-containing inositol
polyphosphate 50-phosphatase (SHIP1) as a critical regulator in
the suppression of mast cell degranulation in response to supra-
optimal allergen-IgE crosslinking (Huber, 2013). In this study, us-
ing a two-allergen model, we sought to investigate further the
conditions where supraoptimal allergen-IgE crosslinking results
in reduced mast cell degranulation. This was accomplished by
using two allergens, each specific for a different monoclonal
IgE, at varying concentrations to assess the conditions where
the effect of the second allergen resulted in increased degranu-
lation, no change in degranulation, and decreased degranulation
associated with supraoptimal IgE crosslinking. Additionally, we
evaluated how the degranulation response changes with de-
creasing percentage of allergen-specific IgE.
RESULTS
Design of the Two-Allergen Model
In our previous work, we described the design, synthesis, and
characterization of synthetic tetravalent allergens (Handlogten
et al., 2012, 2013a, 2013b). These well-defined tetravalent aller-
gens have several advantages compared to the widely used
haptenated proteins, such as 2,4-Dinitrophenyl hapten (DNP)
conjugated to BSA (DNP-BSA), as model allergens. The method
used to synthesize these widely used allergens relies on the
nonspecific conjugation of DNP to the ε-amine of lysine residues
of BSA. This process results in poorly defined allergens with sig-
nificant heterogeneity in both the number of haptens per protein
and the sites of hapten conjugation, resulting in variable potency
from batch to batch. This complicates results as only the average
number of haptens per carrier can be determined, with many of
the haptens likely unavailable to bind to surface-bound IgE due
to steric constraints (Hlavacek et al., 1999; Xu et al., 1998). As a
result, a small subpopulation of the synthetic allergen, with prop-
erties distinct from the average,may be responsible for themajor-
ity of the degranulation response. In the design of the tetravalent
allergens, we ensured that each hapten is available to bind to a
distinct IgE antibody without the capacity to bind bivalently to a
single IgE. In addition, the tetravalency models the valency of
several common allergens, including Ara h 3 from peanuts, Tri a
14 from wheat, and Cuc m 2 from melon, each of which have
four immunodominant epitopes (Denery-Papini et al., 2011; Rab-
john et al., 1999; Tordesillas et al., 2010). Finally, the synthetic
scheme used for the tetravalent allergens ensures that each1, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1445
Figure 1. Characterization and Structure of
the HmTAs
(A) Structures of the haptens DNP and dansyl used
in the tetravalent allergens.
(B) The affinity of each hapten was determined for
its specific IgE using a fluorescence-quenching
technique (Supplemental Information). The KD of
DNP for IgEDNP was 22 ± 2 nM, and the KD of
dansyl for IgEdansyl was 54 ± 4 nM. Data represent
the means ± SD of triplicate experiments.
(C) Structures of the synthetic allergens HmTA
[DNP4], HmTA [dansyl4], and HmBA [DNP2].
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properties on the stimulation of mast cell degranulation. In the
present study, we used two homotetravalent allergens (HmTAs),
each specific for a different IgE, to model the multiple major aller-
gens found in typical allergen sources. In addition, we used a
third, non-allergen-specific IgE to better represent the heteroge-
neity of IgE present onmast cell surfaces. The two-allergenmodel
provides a more physiologically relevant allergy system to eval-
uate the effect of multiple allergy-inducing proteins present in
typical allergen sources on mast cell degranulation.
Evaluation of the Tetravalent Allergens
The two-allergenmodel required two hapten/IgE pairs and a third
non-allergen-specific IgE. The DNP/IgEDNP pair is the most
commonly used system to study mast cell degranulation; conse-
quently, it was selected as the first hapten/IgE pair (Andrews
et al., 2009; Passante and Frankish, 2009). The second hapten/
IgE pair selected was dansyl/IgEdansyl. This hapten/IgE pair was
selected because dansyl, similar to DNP, is a small molecule
that is easily incorporated into multivalent designs (Figure 1A).
Finally, IgEcyclin A was selected as the third IgE to represent IgE1446 Chemistry & Biology 21, 1445–1451, November 20, 2014 ª2014 Elsevier Ltd All rights reof other specificity present on the surface
of mast cells. The first step in character-
izing the two-allergen model was to de-
termine the affinity of DNP and dansyl
for their respective IgE antibodies using
a fluorescence-quenching assay as des-
cribed previously (Handlogten et al.,
2011). Using this technique, we deter-
mined that the dissociation constant, KD,
of DNP for IgEDNP was 22 ± 2 nM and
that the KD of dansyl for IgE
dansyl was
54± 4 nM (Figure 1B).With the same tech-
nique, we also determined there was no
cross-reactivity between the hapten/IgE
pairs (Figure S1 available online).
Next, tetravalent versions of both DNP
and dansyl were synthesized by conju-
gating each hapten to the tetravalent
scaffold resulting in HmTA DNP (HmTA
[DNP4]) and HmTA dansyl (HmTA [dan-
syl4]; Figure 1C). In addition, a homo-
bivalent allergen DNP (HmBA [DNP2])
with a structure identical to that of
HmTA [DNP4], except with two acetylatedarms, was also synthesized to evaluate the effect of allergen va-
lency on mast cell degranulation (Figure 1C). To further establish
that there was no cross-reactivity in the IgE-allergen pairs, mast
cells were primed with IgEDNP, IgEdansyl, or IgEcyclin A and
exposed to increasing concentrations of the synthetic allergens.
As expected, the tetravalent allergens only stimulated a res-
ponse when the mast cells were primed with the allergen-spe-
cific IgE, IgEDNP for HmTA[DNP4], or IgE
dansyl for HmTA [dansyl4]
(Figure 2). Both HmTA [DNP4] and HmTA [dansyl4] stimulated a
similar percent degranulation; however, the HmTA [DNP4]
allergen proved to be more potent, stimulating a maximum
response at 10 nM compared to 100 nM for HmTA [dansyl4].
This is likely a reflection of the difference in affinities of DNP for
IgEDNP (KD = 22 nM) compared to dansyl for IgE
dansyl (KD =
54 nM). In line with previous work, the bivalent allergen HmBA
[DNP2] failed to stimulate a response under any condition due
to insufficient valency (Figure 2) (Posner et al., 2007; Sil et al.,
2007). Combined, these results validate that there is no cross-
reactivity between the IgE-hapten pairs and demonstrate the
suitability of the two-allergen model for investigating the effect
of multiple unique allergens on mast cell degranulation.served
Figure 2. Specificity of the Tetravalent Allergens
RBL cells were primed with (A) IgEDNP, (B) IgEdansyl, and (C) IgEcyclin A and then
exposed to increasing concentrations of the synthetic allergens HmTA [DNP4],
HmTA [dansyl4], and HmBA [DNP2] to determine maximum degranulation
response. HmTA [DNP4] and HmTA [dansyl4] only stimulated a response when
the RBL cells were primed with IgEDNP and IgEdansyl, respectively. HmBA
[DNP2] did not stimulate a response under any condition. Data represent the
means ± SD of triplicate experiments.
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Chemistry & Biology 21, 1445–145Evaluation of the Two-Allergy Model System
Next, rat basophilic leukemia (RBL) cells were primed with an
equimolar solution of IgEDNP and IgEdansyl. We previously estab-
lished that the relative concentration of each IgE in solution is
preserved on the surface of the mast cells (Handlogten et al.,
2012). The mast cells were then exposed to mixtures of HmTA
[DNP4] and HmTA [dansyl4], with concentrations ranging from
0.5 nM to 1,000 nM (Figure 3; Figure S2). These results revealed
a complex relationship between allergen concentration and the
respective degranulation response. For low concentrations of
HmTA [DNP4] and HmTA [dansyl4], the presence of both aller-
gens resulted in increased degranulation; for moderate allergen
concentrations, the presence of a second allergen did not
change the degranulation response; and for high allergen con-
centrations, the presence of a second allergen decreased the
degranulation response. Interestingly, at the highest allergen
concentrations, the overall degranulation response began to in-
crease again as observed with HmTA [dansyl4] concentrations of
50 and 100 nM (Figure 3). The bell-shaped dose-response curve
has traditionally been attributed to the degree of IgE aggregation
(Huber, 2013; Posner et al., 2007; Sil et al., 2007). As the allergen
concentration increases, the degree of IgE crosslinking in-
creases up to a point when monovalent allergen-IgE interactions
begin to dominate due to excess allergen. According to this
model, the presence of the second allergen could result in either
increased degranulation when administered at moderate con-
centrations or no change in degranulation when administered
at very high or very low concentrations. Instead, we observed
that, at HmTA [dansyl4] concentrations above 50 nM when
the concentration of HmTA [DNP4] exceeded 10 nM, the degran-
ulation response decreased (Figure 3; Figure S2). Since these
allergens each bind to a separate IgE, the decrease in the deg-
ranulation response cannot be attributed to competitive inhibi-
tion of IgE crosslinking caused by excess allergen. Instead, there
is an optimal degree of IgE crosslinking on the surface of mast
cells, above which there are inhibitory pathways that become
active to limit the degranulation response (Huber, 2013). Accord-
ingly, the degranulation response continues to increase with
allergen concentration until the optimal degree of IgE crosslink-
ing is reached, as observed by the increased degranulation
response with low concentrations of HmTA [DNP4] and HmTA
[dansyl4] each. As the degree of crosslinking approaches the
optimal amount, the additive effect of the second allergen de-
creases, as observed by the degranulation response with mod-
erate concentrations of both HmTA [DNP4] and HmTA [dansyl4].
Finally, as the degree of crosslinking increases beyond the
optimal level, the degranulation response decreases regardless
of which allergen is causing the increased IgE crosslinking, as
demonstrated by a decrease in degranulation observed at high
concentrations of HmTA [DNP4] and HmTA [dansyl4].
Next, we investigated how the degranulation response
changed with decreasing percent specific IgE by incorporating
IgEcyclin A. As can be seen in Figures 3 and S2, the trends
observed with RBL cells primed with the 50/50 mix of IgEDNP
and IgEdansyl are similar to those primed with the 25/25/50 and
15/15/70 mixes of IgEDNP/IgEdansyl/IgECyclin A. However, as the
percent specific IgE is further decreased to 10/10/80 and 5/5/
90: IgEDNP/IgEdansyl/IgEcyclin A, the degranulation response ex-
hibited a subtle change (Figure 3). Maximum degranulation still1, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1447
Figure 3. Two-Allergen Model Reveals Complex Relationship between IgE Crosslinking and Degranulation
RBL cells were primed with mixtures of IgE (50/50/0, 25/25/50, 15/15/70, 10/10/80, 5/5/90, and 1/1/98: IgEDNP/IgEdansyl/IgEcyclin A) at a saturating total IgE
concentration of 1 mg/ml. The cells were washed and then exposed to mixtures of HmTA [DNP4] with HmTA [dansyl4], ranging from 0.5 to 1,000 nM concentration
of each allergen. Data represents the means ± SD of triplicate experiments.
See also Figure S2.
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degranulation previously observed with an increasing HmTA
[DNP4] concentration to 50 nM did not occur. Instead, the
degranulation response reached a plateau at 10 nM HmTA
[DNP4] and did not begin to decrease significantly until a concen-
tration of 100 nM HmTA [DNP4]. This suggests that, since there
was a lower percentage of allergen-specific IgE on the surface
of the mast cells, a higher concentration of the allergen was
required to reach the same degree of IgE crosslinking. The bind-
ing curve of DNP to IgEDNP (Figure 1B) supports this theory.
While the DNP-IgEDNP KD is 22 nM (50% bound), 100% binding
does not occur until 200 nM, demonstrating that there is
increased binding of allergen to the surface-bound IgE until a
concentration of 200 nM. Furthermore, as the percentage of
allergen-specific IgE was decreased to 1/1/98: IgEDNP/IgEdansyl/
IgEcyclin A, the degranulation response stimulated by the two
allergens was approximately additive at all allergen concentra-
tions. This result suggests that, with only 1% specific IgE for
each allergen, there is not sufficient IgE to attain supraoptimal
IgE crosslinking.
To further demonstrate that the changes in degranulation
observed in Figure 3 were due to changes in IgE crosslinking
and not due to some other property of DNP, we used a monova-
lent DNP ligand in place of HmTA [DNP4]. The RBL cells were
primed with 25/25/50: IgEDNP/IgEdansyl/IgEcyclin A, which was1448 Chemistry & Biology 21, 1445–1451, November 20, 2014 ª2014the condition where maximum degranulation was observed (Fig-
ure 3). Then, the RBL cells were exposed to mixtures of HmTA
[dansyl4] and monovalent DNP, with the concentration of each
ranging from 0.5 to 1,000 nM (Figure 4A). As expected, the
monovalent DNP ligand did not cause any significant change in
the degranulation response, demonstrating that the differences
in observed degranulation with increasing concentrations of
HmTA [DNP4] in Figure 3 were due to changes in the crosslinking
of the IgE antibodies on the RBL cell surface.
Several molecules have recently been identified as having a
role in inhibitory pathways that limit degranulation in response
to supraoptimal IgE crosslinking. Among these molecules,
SHIP1 has been identified as a critical negative regulator of
mast cell degranulation as demonstrated using SHIP1-deficient
mast cells. SHIP1-deficient mast cells do not exhibit reduced
degranulation in response to supraoptimal allergen concentra-
tions (Gimborn et al., 2005; Kraft and Kinet, 2007; Molfetta
et al., 2007). Therefore, we investigated the phosphorylation of
SHIP1 using the two-allergen model. RBL cells were stimulated
with 100 nM HmTA [Dansyl4], the concentration that elicited
the highest response (Figure 2B), with HmTA [DNP4] increasing
from 0.5 to 1,000 nM. Based on the results in Figure 3, we antic-
ipated that there would be little phosphorylation of SHIP1 at the
lowest concentrations of HmTA [DNP4], as these were the condi-
tions where maximum degranulation occurred, and that theElsevier Ltd All rights reserved
Figure 4. Effect of Valency on Degranula-
tion in Two-Allergen Model
(A) RBL cells were primed with 25/25/50: IgEDNP/
IgEdansyl/IgEcyclin A and then exposed to mixtures
of HmTA [dansyl4] and monovalent DNP ranging
from 0.5 to 1,000 nM.
(B) RBL cells were primed with an equimolar
solution of IgEDNP and IgEdansyl and then stimu-
lated with 100 nM of HmTA [dansyl4] with 0.5–
1,000 nM of HmTA [DNP4]. The postnuclear
supernatants were subjected to anti-SHIP immu-
noprecipitation and then anti-phospho-tyrosine
and anti-SHIP immunoblotting to demonstrate
equal loading.
(C) RBL cells were primed with mixtures of IgEs (0/
25/75, 25/25/50, 50/25/25, and 75/25/0: IgEDNP/
IgEdansyl/IgEcyclin A) at a total IgE concentration of
1 mg/ml, followed by exposure to 100 nM HmTA
[dansyl4] with HmBA [DNP2] ranging from 0.5 to
1,000 nM. Data represent the means ± SD of
triplicate experiments.
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concentration to account for the decreased degranulation
observed in Figure 3. Indeed, as observed in Figure 4B, the
phosphorylation of SHIP1 increased with the HmTA [DNP4] con-
centration, confirming the role of SHIP1 as a negative regulator
of mast cell degranulation that is activated in response to supra-
optimal IgE crosslinking.
Bivalent allergens have been previously shown to form cyclic
dimers with IgE, and these clusters of cyclic dimers typically do
not stimulate a degranulation response (Posner et al., 2007; Sil
et al., 2007). We next investigated if the bivalent DNP allergenChemistry & Biology 21, 1445–1451, November 20, 2014 ªHmBA [DNP2], which was unable to stim-
ulate mast cell degranulation (Figure 2),
was able to decrease the degranulation
response caused by HmTA [dansyl4]. For
these experiments, the RBL cells were
primed with four different IgE mixtures
that had the same percent IgEdansyl with
increasing percent IgEDNP. The mixtures
were 0/25/75, 25/25/50, 50/25/25, and
75/25/0: IgEDNP/IgEdansyl/IgEcyclin A. The
RBL cells were then exposed to 100 nM
HmTA [dansyl4], with increasing concen-
trations of HmBA [DNP2]. As observed in
Figure 4B, in the absence of IgEDNP, the
bivalent allergen HmBA [DNP2] had no
effect on mast cell degranulation. How-
ever, as the percentage of IgEDNP was
increased, there was a small reduction in
the degranulation response observed
from 5 to 100 nM HmBA [DNP2]. The
reduction in degranulation response dis-
appeared by 1,000 nM HmBA [DNP2],
presumably as IgEDNP crosslinking was
inhibited due to excess HmBA [DNP2] in
solution. The partial inhibition of degranu-
lation observed with HmBA [DNP2] sug-
gests that only large, signaling-competentclusters of IgE are capable of activating the pathways responsible
for limiting the degranulation response.
DISCUSSION
Mast cell degranulation experiences a bell-shaped dose-
response behavior with increasing allergen concentration. This
response has traditionally been attributed to excess allergen
competitively inhibiting IgE crosslinking on the mast cell surface,
such that, at high allergen concentrations, each IgE is bound
monovalently to a different allergen, preventing the formation2014 Elsevier Ltd All rights reserved 1449
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Supraoptimal Crosslinking Decreases Degranulationof signaling-competent clusters. Using the two-allergen model,
we were able to demonstrate that the decrease in degranulation
cannot be due to a decrease in IgE crosslinking but, to the con-
trary, is due to a further increase in IgE crosslinking. The speci-
ficity of the hapten-IgE pairs ensured that IgE crosslinking
caused by the first allergen-IgE interactions on the RBL cells
was not inhibited by the second allergen. Consequently, the
decreased degranulation observed at high concentrations of
both HmTA [DNP4] and HmTA [dansyl4] was due to increased
IgE crosslinking. This confirms recent evidence suggesting that
the decrease in degranulation at high allergen concentrations
is caused by active inhibitory pathways (Huber, 2013). In partic-
ular, SHIP1 has been identified as a key regulator of mast cell
degranulation, which we confirmed using our two-allergen
model. However, the results in Figure 3 demonstrate that when
mast cells were primed with high levels of allergen-specific IgE
and stimulated 50 or 100 nM HmTA [dansyl4], the degranulation
response increased as the concentration of HmTA [DNP4]
increased from 500 to 1,000 nM, despite increased SHIP1 phos-
phorylation (Figure 4B). The mechanisms through which SHIP1
and other regulatory molecules limit the degranulation response
have yet to be fully elucidated. Further investigation and iden-
tification of the molecules involved in the suppression of deg-
ranulation will likely lead to the identification of novel molecular
targets that could be exploited to treat patients with acute and
chronic allergic diseases. The two-allergen model is uniquely
suited to analyze the effect of supraoptimal IgE crosslinking on
mast cell degranulation and to elucidate these critical aspects
regulating mast cell degranulation.
SIGNIFICANCE
Most allergen sources contain a complex mixture of aller-
gens, many of which are capable of stimulating a strong
allergic response on their own, yet current allergen model
systems use a single allergen specific for a single mono-
clonal IgE antibody. To investigate the influence of each
allergen in these complex mixtures, we used two well-
defined tetravalent allergens, each specific for a distinct
IgE, to model an allergen source containing multiple aller-
gens. In addition, we used a third, non-allergen-specific
IgE to represent the heterogeneity of IgE present on mast
cells. This system allowed us to investigate how the pres-
ence of two allergens effect the overall degranulation
response and how the response stimulated by the two aller-
gens changes as the percent IgE specific for each allergen is
varied. Using this system, we demonstrated that, at low
allergen concentrations, the presence of a second allergen
increases the degranulation response; at moderate allergen
concentrations, the second allergen does not change the
degranulation response; and at high allergen concentra-
tions, the degranulation response decreases. Traditionally,
the decreased degranulation observed at high allergen con-
centrations has been attributed to a decrease in IgE cross-
linking caused by excess allergen in solution competitively
inhibiting allergen-IgE interactions. However, each of the
two allergens is specific for a different IgE, so the decreased
degranulation cannot be attributed to decreased IgE cross-
linking. Therefore, our results provide further evidence of1450 Chemistry & Biology 21, 1445–1451, November 20, 2014 ª2014recently identified active inhibitory pathways that regulate
mast cell degranulation. The mechanisms through which
supraoptimal IgE crosslinking decreases the degranulation
response remain to be fully elucidated, and it is likely that
further study of these pathways, using more physiologically
relevant systems such as the two-allergenmodel, will lead to
novel molecular targets for treating allergy and asthma.
EXPERIMENTAL PROCEDURES
Fluorescence Quenching Binding Assay
The binding constants of the monovalent haptens to the respective IgEs were
determined using a previously described fluorescence quenching assay
(Handlogten et al., 2011).
Synthesis of the Tetravalent and Bivalent Synthetic Allergens
All molecules were synthesized using standard Fmoc chemistry on a solid sup-
port as described in the Supplemental Information.
Degranulation Assays
IgEdansyl (clone 27-74) and IgEcyclin A (clone BF683) were purchased from BD
Biosciences. Degranulation assays were carried out as previously described
(Handlogten et al., 2011).
Immunoprecipitation and Western Blotting
RBL cells were incubated overnight with an equimolar solution of IgEDNP and
IgEdansyl. Cells were washed twice and re-equilibrated to 37C for 30 min prior
to stimulation with the indicated allergen mixtures for 3 min. After stimulation,
cells were scraped on ice, pelleted, and solubilized with 0.5% NP-40 and
0.5% deoxycholate in 4C phosphorylation solubilization buffer. Samples
were normalized for protein content and then subjected to immunoprecipitation
using agarose-conjugated monoclonal anti-SHIP antibody (P1C1) from Santa
Cruz Biotechnologywith three subsequent washing stepswith phosphorylation
buffer containing 0.5% NP-40. The precipitate was separated by SDS-PAGE
and analyzed using western blotting using an anti-p-Tyr antibody (PY99) from
Santa Cruz Biotechnology or monoclonal anti-SHIP antibody (P1C1) from
Santa Cruz Biotechnology as previously described (Gimborn et al., 2005).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2014.08.019.
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